Recent Blog Posts

View Post: How Big Pharma Profits from Swine Flu
18 hours ago by BusinessWeek: Investing  
Vasella says increased investment in vaccine research and development, clinical trials, and manufacturing are the reason for the losses. The company, for instance, spent $200 million over the past three years building a second ...
View Blog: Currency Trading - http://tradercurrencies.com/currency-trading/

---

View Post: H1N1 Vaccine Development on ADVANCE for Respiratory Care and Sleep ...
22 Nov 2009 by By Amanda Koehler  
Even though development of the H1N1 vaccine is only slightly different from that of seasonal flu vaccine, Poland said much more surveillance is being done on H1N1 vaccine to ease people's concerns. ...
View Blog: ADVANCE for Respiratory Care and Sleep Medicine - http://respiratory-care-sleep-medicine.advancew...

---

View Post: Where We Really Need Vaccine Development « O'Ceallaigh & The Quill
14 Nov 2009 by The Amoeba  
Where We Really Need Vaccine Development. Your Friendly Neighborhood Amoeba has just found out that, since April 2009 in the Untied States of America, about 4000 people have died, and about 98000 have been hospitalized, from influenza ...
View Blog: O'Ceallaigh & The Quill - http://ocquill.wordpress.com/

---

View Post: Big Pharma's vaccine run marks
GDS Publishing
23 Nov 2009 ...
View Blog: http://www.ngpharma.com/

---

View Post: Africa Region Leaders Meet To Discuss H1N1 Procurement ...
24 Nov 2009
The article examines several promising new technologies that would speed up vaccine development, noting, "While several companies are trying to ready their new techniques in case the H1N1 pandemic worsens, most of these remain years ...
View Blog: Kaiser Daily Global Health Policy Report - http://globalhealth.kff.org/

---

View Post: Issues with Vaccine Development for HIV/AIDS « Health and Life
13 Nov 2009 by admin  
There are additional targets for vaccine development that have yet to be tried, especially the tat gene and product. And there are exciting new methods of vaccine delivery and design that may allow better targeting and response. ...
View Blog: Health and Life - http://healthlifeandstuff.com/

---

View Post: Tick Saliva: New Target for Lyme Disease Vaccine : Target Health ...
23 Nov 2009 by targethealth  
Fikrig, who is chief of infectious diseases at the Yale School of Medicine, said vaccine development - even as far back as Louis Pasteur's discoveries in the 1880s - has historically relied on using a weakened form of the pathogen, ...
View Blog: Target Health Global - http://blog.targethealth.com/

---

View Post: Studying an AIDS vaccine: BYU prof helps create road map for ...
14 hours ago
“The virus that's out there in the world by that point is very different from the virus that was being targeted during vaccine development.” Another contribution of the new study is value of the data to future research. ...
View Blog: BYU News - http://news.byu.edu/

---